Education
About Us
Working with TipRanks
Follow Us
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
Supernus Pharmaceuticals (SUPN) Ownership Overview
4.32% Insiders
34.90% Mutual Funds
12.72% Other Institutional Investors
26.67% ETFs
21.39% Public Companies and
Individual Investors
The ownership structure of Supernus Pharmaceuticals (SUPN) stock is a mix of institutional, retail, and individual investors. Approximately 74.29% of the company’s stock is owned by Institutional Investors, 4.32% is owned by Insiders, and 21.39% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 10, 2025 | xxxxxxxxxxxxx | $3029336 | |
Oct 03, 2025 | xxxxxxxxxxxxx | $91506 | |
Oct 02, 2025 | xxxxxxxxxxxxx | $1931116 | |
Oct 01, 2025 | xxxxxxxxxxxxx | $414371 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $9827528 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,431,810 | Institution | 11.22% | 326,993,220 | |
| 5,729,042 | Institution | 9.99% | 291,264,495 | |
| 5,121,843 | Institution | 8.93% | 260,394,498 | |
| 4,363,748 | Institution | 7.61% | 221,852,948 | |
| 2,212,178 | Insider | 3.86% | 112,467,130 | |
| 1,714,841 | Institution | 2.99% | 87,182,516 | |
| 1,263,811 | Institution | 2.20% | 64,252,151 | |
| 1,078,905 | Institution | 1.88% | 54,851,530 | |
| 718,707 | Institution | 1.25% | 36,539,064 | |
| 681,350 | Institution | 1.19% | 34,639,834 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,729,042 | Institution | 9.99% | 291,264,495 | |
| 4,363,748 | Institution | 7.61% | 221,852,948 | |
| 1,714,841 | Institution | 2.99% | 87,182,516 | |
| 718,707 | Institution | 1.25% | 36,539,064 | |
| 608,858 | Institution | 1.06% | 30,954,341 | |
| 551,590 | Institution | 0.96% | 28,042,836 | |
| 521,347 | Institution | 0.91% | 26,505,281 | |
| 388,486 | Institution | 0.68% | 19,750,628 | |
| 375,471 | Institution | 0.65% | 19,088,946 | |
| 358,847 | Institution | 0.63% | 18,243,781 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,470,485 | Institution | 6.05% | 176,439,457 | |
| 1,715,651 | Institution | 2.99% | 82,625,752 | |
| 1,331,382 | Institution | 2.32% | 67,687,461 | |
| 1,233,899 | Institution | 2.15% | 59,424,576 | |
| 792,213 | Institution | 1.38% | 38,152,978 | |
| 619,876 | Institution | 1.08% | 29,853,228 | |
| 530,192 | Institution | 0.92% | 26,430,071 | |
| 422,851 | Institution | 0.74% | 21,497,745 | |
| 335,593 | Institution | 0.59% | 17,061,548 | |
| 275,941 | Institution | 0.48% | 13,755,659 |
FAQ
Who Owns Supernus Pharmaceuticals (SUPN)?
According to the latest TipRanks data, approximately 12.72% of the company's stock is held by institutional investors, 4.32% is held by insiders, and 21.39% is held by retail investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.72% of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors.
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.39% of Supernus Pharmaceuticals (SUPN) stock is held by retail investors.
Who owns the most shares of Supernus Pharmaceuticals (SUPN)?
iShares owns the most shares of Supernus Pharmaceuticals (SUPN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.